Is there evidence supporting the role of SBRT in the management of oligometastatic stage IV NSCLC?
How does this apply to patients with brain-only oligometastases?
Answer from: Radiation Oncologist at Community Practice
Yes. I would look at a great trial from Wake Forest, looking at consolidative radiotherapy after 3-6 cycles of platinum-based chemotherapy, followed by observation, so chemotherapy, then radiotherapy, then observation (no maintenance chemotherapy). The trial occurred from 2010 to 2015. This single-a...
Comments
Medical Oncologist at Saint Louise Regional Hospital How do you reconcile these phase 2 results with ph...
Radiation Oncologist at University of Texas at Tyler My understanding of NRG-LU002 is that its design w...
Answer from: Radiation Oncologist at Community Practice
To define a population undergoing active treatment with effective systemic agents that might benefit from LCT requires a nuanced approach, given that tumor response may operate in a time-dependent manner depending on the systemic agent used. The definition of oligometastasis: site, volume, and numbe...
Comments
Medical Oncologist at Saint Louise Regional Hospital While the retrospective trials and phase II trials...
Radiation Oncologist at University of Texas at Tyler The populations of these trials differed by system...
How do you reconcile these phase 2 results with ph...
My understanding of NRG-LU002 is that its design w...